Clinical Roundup City of Hope blood test shows promise for detecting pancreatic cancer at its earliest stages September 18, 2026Vol.52 No.34
Clinical Roundup UT Austin study uncovers new driver of immunotherapy resistance in pancreatic cancer September 18, 2026Vol.52 No.34
Clinical Roundup Ris-Rez reduced risk of death by 54% vs. topotecan in patients with relapsed SCLC, phase III trial in China finds September 18, 2026Vol.52 No.34
Clinical Roundup Rybrevant + chemo delivers longest reported median OS in EGFR exon 20 insertion mutation-positive lung cancer September 18, 2026Vol.52 No.34
Clinical Roundup AI imaging endpoint predicts OS benefit in phase III lung cancer trial: data presented at IASLC WCLC 2026 September 18, 2026Vol.52 No.34
Clinical Roundup Registrational phase II trial of arlo-cel meets primary endpoint in RRMM September 18, 2026Vol.52 No.34
Clinical Roundup Salk institue team discovers novel pathway, provides insights to combat immunotherapy resistance September 18, 2026Vol.52 No.34
Clinical Roundup Anti-seizure drug fights aggressive childhood brain tumors, Stanford Medicine-led study shows September 18, 2026Vol.52 No.34
Clinical Roundup Personalized weight-loss care benefits breast cancer survivors, JHU-led study finds September 18, 2026Vol.52 No.34
Clinical Roundup ASTRO updates guideline on radiation therapy for pancreatic cancer September 11, 2026Vol.52 No.33
